Status:
COMPLETED
Two Investigational Drugs in Patients With Mixed Hyperlipidemia (0653-036)
Lead Sponsor:
Organon and Co
Conditions:
Hypercholesterolemia
Hypertriglyceridemia
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the cholesterol lowering effectiveness and safety of two investigational drugs in patients with mixed hyperlipidemia (high cholesterol and high triglycerides).
Detailed Description
The duration of treatment is 18 weeks.
Eligibility Criteria
Inclusion
- High cholesterol and high triglycerides
Exclusion
- Patient has a condition which, in the opinion of the investigator, might pose a risk to the patient, interfere with participation in the study, or does not meet the additional criteria as required by the study
Key Trial Info
Start Date :
December 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2003
Estimated Enrollment :
587 Patients enrolled
Trial Details
Trial ID
NCT00092560
Start Date
December 1 2002
End Date
December 1 2003
Last Update
August 15 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.